Engage with CRR-UAE.

For senior representatives whose experience and perspective are relevant to a specific Roundtable theme. Participation provides the opportunity to join one carefully curated discussion with stakeholders from the parts of the ecosystem most relevant to the topic.

• One seat at one specific CRR-UAE Roundtable
• Participation by one senior representative
• Opportunity to contribute experience and perspectives to the discussion
• Access to the relevant Roundtable agenda and findings

Participation is subject to thematic relevance and Roundtable composition. CRR-UAE independently curates each table to ensure the appropriate expertise and balance of perspectives. Payment does not automatically secure participation.

For organisations that want to remain engaged with CRR-UAE throughout the year and contribute to the wider programme beyond an individual Roundtable.

The Strategic Advisory Partnership is open to organisations from across the life-sciences, healthcare, technology and investment communities whose perspective is relevant to the development of clinical research in the UAE.

• Structured engagement with the CRR-UAE Founding Members throughout the year
• Opportunities to contribute priorities, expertise and perspectives to the wider programme
• Access to agendas and findings across the CRR-UAE programme
• Participation in at least one Roundtable per year, subject to thematic relevance, with priority consideration where the organisation's expertise is relevant
• Relevant ecosystem connections and introductions where there is a genuine reason for CRR-UAE to facilitate them
• Participation in dedicated Strategic Advisory Partner discussions with the CRR-UAE Founding Members
• Recognition as a CRR-UAE Strategic Advisory Partner on appropriate CRR-UAE channels and materials

Strategic Advisory Partners may share priorities, challenges and perspectives that can help CRR-UAE identify relevant questions and areas for future discussion. CRR-UAE retains independent editorial and programme control.

For pharmaceutical companies and CROs that want to work collectively on shared priorities affecting the conduct and growth of clinical trials in the UAE.

The Pharma Working Group provides a dedicated forum for industry to identify common challenges and opportunities, develop priorities and engage with relevant stakeholders where broader dialogue can help move those priorities forward.

• Structured engagement with participating pharmaceutical companies and CROs throughout the year
• Identification and prioritisation of shared industry challenges and opportunities affecting clinical trials in the UAE
• Dedicated discussions on areas such as patient recruitment, site capabilities, laboratories, contracting, study start-up, regulatory processes and operational barriers
• Development and follow-up of agreed priorities throughout the year
• Engagement with relevant hospitals, regulators, government entities, patient organisations and other stakeholders where broader dialogue is appropriate
• Opportunities to bring relevant priorities into wider CRR-UAE discussions and Roundtables where multi-stakeholder perspectives would add value
• Access to relevant findings and outputs developed through the Working Group
• Relevant ecosystem connections and introductions where there is a genuine reason for CRR-UAE to facilitate them

The Pharma Working Group provides a structured environment for pharmaceutical companies and CROs to work on shared industry priorities. CRR-UAE facilitates dialogue and engagement with relevant stakeholders where appropriate but does not represent the industry, guarantee regulatory engagement or outcomes, or replace existing industry associations.